{"id":"https://openalex.org/W43106749","doi":null,"title":"Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.","display_name":"Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.","publication_year":1997,"publication_date":"1997-06-01","ids":{"openalex":"https://openalex.org/W43106749","mag":"43106749","pmid":"https://pubmed.ncbi.nlm.nih.gov/9208343"},"language":"en","primary_location":{"id":"pmid:9208343","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9208343","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111697742","display_name":"Wolfgang M. M\u00fcck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"W M\u00fcck","raw_affiliation_strings":["Institute of Clinical Pharmacology, Bayer AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Clinical Pharmacology, Bayer AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087309543","display_name":"W. Ritter","orcid":"https://orcid.org/0000-0001-6297-0254","observed_orcids":["https://orcid.org/0000-0001-6297-0254"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Ritter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"H Dietrich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Dietrich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079419308","display_name":"R Frey","orcid":"https://orcid.org/0000-0002-5240-2680","observed_orcids":["https://orcid.org/0000-0002-5240-2680"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Frey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027440900","display_name":"J. Kuhlmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Kuhlmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.7825,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.95717182,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"6","first_page":"261","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9160000085830688,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.05559999868273735,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cerivastatin","display_name":"cerivastatin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/maalox","display_name":"Maalox","score":0.7919999957084656},{"id":"https://openalex.org/keywords/cimetidine","display_name":"cimetidine","score":0.9810000061988831},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7490000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9610000252723694},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8949999809265137},{"id":"https://openalex.org/keywords/antacids","display_name":"antacids","score":0.9120000004768372},{"id":"https://openalex.org/keywords/h2-receptor-antagonists","display_name":"H2 receptor antagonists","score":0.7950000166893005},{"id":"https://openalex.org/keywords/intragastric-ph","display_name":"gastric pH","score":0.7860000133514404},{"id":"https://openalex.org/keywords/drug-absorption","display_name":"drug absorption","score":0.6060000061988831},{"id":"https://openalex.org/keywords/cytochrome-p450-inhibition","display_name":"cytochrome P450 inhibition","score":0.7960000038146973},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8799999952316284},{"id":"https://openalex.org/keywords/magnesium-aluminum-hydroxide","display_name":"magnesium aluminum hydroxide","score":0.753000020980835},{"id":"https://openalex.org/keywords/auc","display_name":"AUC","score":0.46700000762939453},{"id":"https://openalex.org/keywords/cmax","display_name":"Cmax","score":0.9909999966621399}],"concepts":[{"id":"https://openalex.org/C2779415389","wikidata":"https://www.wikidata.org/wiki/Q423439","display_name":"Cerivastatin","level":4,"score":0.9336060285568237},{"id":"https://openalex.org/C2780590083","wikidata":"https://www.wikidata.org/wiki/Q274083","display_name":"Antacid","level":2,"score":0.8903151750564575},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.799439549446106},{"id":"https://openalex.org/C2780719153","wikidata":"https://www.wikidata.org/wiki/Q409492","display_name":"Cimetidine","level":2,"score":0.764445424079895},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.739398717880249},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6415044069290161},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5783746838569641},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.534421980381012},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4816490709781647},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.42319053411483765},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.41389375925064087},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3030723035335541},{"id":"https://openalex.org/C134651460","wikidata":"https://www.wikidata.org/wiki/Q3100717","display_name":"Reductase","level":3,"score":0.2142690122127533},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.13033318519592285},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10662376880645752},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0881890058517456},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05243152379989624},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000536","descriptor_name":"Aluminum Hydroxide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000536","descriptor_name":"Aluminum Hydroxide","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000536","descriptor_name":"Aluminum Hydroxide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000536","descriptor_name":"Aluminum Hydroxide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000863","descriptor_name":"Antacids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000863","descriptor_name":"Antacids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000863","descriptor_name":"Antacids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000863","descriptor_name":"Antacids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002927","descriptor_name":"Cimetidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002927","descriptor_name":"Cimetidine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002927","descriptor_name":"Cimetidine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002927","descriptor_name":"Cimetidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006635","descriptor_name":"Histamine H2 Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006635","descriptor_name":"Histamine H2 Antagonists","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006635","descriptor_name":"Histamine H2 Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006635","descriptor_name":"Histamine H2 Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008276","descriptor_name":"Magnesium Hydroxide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008276","descriptor_name":"Magnesium Hydroxide","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008276","descriptor_name":"Magnesium Hydroxide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008276","descriptor_name":"Magnesium Hydroxide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011863","descriptor_name":"Radioimmunoassay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9208343","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9208343","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Clinical Trial"},{"id":"mag:43106749","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9208343","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2060448683","https://openalex.org/W2410477851","https://openalex.org/W1990212853","https://openalex.org/W2075321235","https://openalex.org/W2101609083","https://openalex.org/W2055676816","https://openalex.org/W2005160306","https://openalex.org/W2026255867","https://openalex.org/W2412616125","https://openalex.org/W2117164965"],"abstract_inverted_index":{"The":[0,88,189],"possible":[1,245],"influence":[2,148],"of":[3,25,71,124,128,134,149,171,181,241,256],"Maalox":[4,85,129],"70,":[5],"an":[6],"antacid":[7],"based":[8],"on":[9,22,131,177],"magnesium-aluminum":[10],"hydroxide,":[11],"and":[12,91,103,110,113,153,192,204,211,214,226,263],"the":[13,23,26,107,117,125,132,147,150,178,208,218,238,253],"H2-antagonist":[14],"cimetidine,":[15],"both":[16],"commonly":[17],"prescribed":[18],"in":[19,34,38,56,247,259],"hypercholesterolemic":[20],"patients,":[21],"pharmacokinetics":[24,133],"new":[27],"HMG-CoA":[28],"reductase":[29],"inhibitor":[30,158],"cerivastatin":[31,74,135,174,227,242],"was":[32,64,136,160],"investigated":[33],"2":[35],"separate":[36],"studies":[37],"8":[39],"healthy":[40,163],"young":[41,164],"male":[42,165],"subjects":[43],"each.":[44],"Cerivastatin":[45],"plasma":[46],"concentration/time":[47],"profiles":[48],"were":[49,75,100,201],"assessed":[50],"by":[51,66,274],"a":[52,139,182],"specific":[53],"HPLC":[54,108,219],"assay;":[55],"addition,":[57],"total":[58],"immunoreactive":[59],"drug":[60],"(cerivastatin":[61],"plus":[62],"metabolites)":[63],"determined":[65],"RIA.":[67],"Single":[68],"oral":[69,169],"doses":[70,170],"200":[72,172],"micrograms":[73,173],"administered":[76],"under":[77],"fasting":[78],"conditions":[79],"without":[80],"or":[81,176],"with":[82],"10":[83],"ml":[84],"70":[86,130],"suspension.":[87],"mean":[89,190],"AUC":[90,191],"Cmax":[92,193],"ratios":[93,194],"(combined":[94,195],"dosing/monodosing)":[95,196],"including":[96,197],"90%":[97,198],"confidence":[98,199],"intervals":[99,200],"0.92":[101],"(0.73-1.15)":[102],"0.89":[104,212],"(0.72-1.10)":[105],"for":[106,116,207,217],"data,":[109,119,210,220],"0.99":[111],"(0.85-1.14)":[112],"1.03":[114],"(0.82-1.30)":[115],"RIA":[118,209],"respectively.":[120],"Thus,":[121],"no":[122],"interaction":[123],"simultaneous":[126],"administration":[127],"observed.":[137],"In":[138],"similar":[140],"controlled,":[141],"randomized":[142],"nonblind":[143],"2-way":[144],"crossover":[145],"design":[146],"H2-":[151],"antagonist":[152],"well-known":[154],"cytochrome":[155,269],"P450":[156,270],"enzyme":[157,271],"cimetidine":[159,184,225],"investigated.":[161],"Eight":[162],"volunteers":[166],"received":[167],"single":[168],"alone":[175],"fourth":[179],"day":[180],"4-day":[183],"400":[185],"mg":[186],"b.i.d.":[187],"pretreatment.":[188],"0.98":[202],"(0.90-1.08)":[203],"0.91":[205],"(0.78-1.07)":[206],"(0.82-0.96)":[213],"0.93":[215],"(0.80-1.09)":[216],"respectively,":[221],"clearly":[222],"indicating":[223],"that":[224,252],"did":[228],"not":[229,235],"interact":[230],"pharmacokinetically.":[231],"These":[232],"results":[233],"do":[234],"only":[236],"reflect":[237],"apparent":[239],"insensitivity":[240],"absorption":[243],"to":[244,268],"changes":[246],"gastric":[248],"pH,":[249],"but":[250],"demonstrate":[251],"metabolic":[254],"pathways":[255],"cerivastatin,":[257],"involved":[258],"its":[260],"first-pass":[261],"metabolism":[262],"elimination,":[264],"are":[265],"rather":[266],"insensitive":[267],"inhibition":[272],"induced":[273],"cimetidine.":[275]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}